Movement Alert｜10x Genomics, Inc. Intraday Rise 5.42% in Regular Trading, Shares Stay Strong After Target Price Reset

Market Focus10-28 21:43

On October 28, 10x Genomics, Inc. rose 5.42% in Regular Trading, trading at $82.4 per share, with turnover of $17.5132 million.

The move coincided with continued market digestion of recent analyst target-price changes. The latest published catalyst was a rating change on October 23, when Stephens downgraded the stock to Equal Weight from Overweight and set a $65 price target. Earlier, on October 9, BofA Securities raised its price target to $80 from $50, well above the FactSet-tracked average target of $58.80 cited in market coverage, indicating that some institutions had lifted their valuation framework for the company.

The stock's price remaining above both the revised $80 target and the broader average target suggests investors are still assigning relatively strong expectations ahead of the next earnings release scheduled for November 5.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment